Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells

Neurotoxicity Research

Volumn 16, Issue 3, 2009, Pages 194-204

  Das, Jharna R ^a   Tizabi, Yousef ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle; Donepezil; Neuroprotection; Nicotine; Parkinson's disease; Salsolinol; SH SY5Y cells

Indexed keywords

ATROPINE; DONEPEZIL; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; SALSOLINOL;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANALYSIS OF VARIANCE; ANNEXIN A5; APOPTOSIS; ATROPINE; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDANS; MECAMYLAMINE; NEUROBLASTOMA; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PIPERIDINES; PROPIDIUM; SALSOLINE ALKALOIDS;

EID: 70349898590     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9040-2     Document Type: Article

References (36)

1. Akaike A (2008) Preclinical evidence of neuroprotection by cholinesterase inhibitors. Eur J Pharmacol 588:189-197
2. Akasofu S, Sawada K, Kosasa T, Hihara H, Ogura H, Akaike A (2006) Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine. Alzheimer Dis Assoc Disord 20:S8-S11
3. Bollimuntha S, Ebadi M, Singh BB (2006) TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis. Brain Res 1099:141-149
4. Copeland RL Jr, Leggett YA, Kanaan YM, Taylor RE, Tizabi Y (2005) Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: Implications for Parkinson's disease. Neurotox Res 8:289-293
5. Copeland RL Jr, Das JR, Kanaan YM, Taylor RE, Tizabi Y (2007) Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12:61-70
6. Dajas-Bailador FA, Soliakov L, Wonnacott S (2002) Nicotine activates the extracellular signal-regulated kinase I/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J Neurochem 80:520-530
7. Di Angelantonio S, Bernardi G, Mercuri NB (2004) Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones. Br J Pharmacol 141:644-652
8. Ebadi M, Pfeffer RF (2005) Parkinson's disease, 1st edn. Taylor and Francis, London
9. Gorell JM, Rybicki BA, Johnson CC, Peterson EL (1999) Smoking and Parkinson's disease: A dose-response relationship. Neurology 52:115-119
10. Guan ZZ, Yu WF, Nordberg A (2003) Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 43:243-249
11. Hayslett RL, Tizabi Y (2003) Effects of donepezil on DOI-induced head twitch response in mice: Implications for Tourette syndrome. Pharmacol Biochem Behav 76:409-415
12. Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S (2003) Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci 24:779-786
13. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284
14. Khwaja M, McCormack A, McIntosh JM, Di Monte DA, Quik M (2007) Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs. J Neurochem 100:180-190
15. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, Akaike A (1998) Stimulation of alpha4 beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792:331-334
16. Liu Q, Zhao B (2004) Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol 141:746-754
17. Maruyama W, Yi H, Takahashi T, Shimazu S, Ohde H, Yoneda F, Iwasa K, Naoi M (2004) Neuroprotective function of R-(-)-1-(benzufuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells. Life Sci 75:107-117
18. Naoi M, Maruyama W, Nagy GM (2004) Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains. Neurotox Res 25:193-204
19. Peng J, Stevenson FF, Oo ML, Andersen JK (2009) Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46:312-320
20. Picciotto MR, Zoli M (2008) Neuroprotection via nAChRs: The role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front Biosci 13:492-504
21. Quik M, McIntosh JM (2006) Striatal alpha6* nicotinic acetylcholine receptors: Potential targets for Parkinson's disease therapy. J Pharmacol Exp Ther 316:481-489
22. Quik M, Bordia T, McIntosh JM (2004) Loss of α-conotoxin MII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum. J Neurochem 88:668-679
23. Quik M, O'Leary K, Tanner CM (2008) Nicotine and Parkinson's disease: implications for therapy. Mov Disord 23:1641-1652
24. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR (2003) Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and l-type calcium channel inactivation. J Neurosci 23:10093-10099
25. Storch A, Schrattenholz A, Cooper JC, Abdel Ghani EM, Gutbrod O, Weber KH, Reinhardt S, Lobron C, Hermsen B, Soskiç V et al (1995) Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Eur J Pharmacol 290:207-219
26. Storch A, Ott S, Hwang Y, Ortmann R, Hein A, Frenzel S, Matsubara K, Ohta S, Wolf H, Schwarz J (2002) Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: Studies using heterologous expression systems of the dopamine transporter. Biochem Pharmacol 63:909-920
27. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A (2008) Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. J Neurosci Res 86:3575-3583
28. Tatton NA (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 166:29-43
29. Tizabi Y, Mastropaolo J, Park CH, Riggs RL, Powell D, Rosse RB, Deutsch SI (1998) Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: Psychiatric implications. Psychopharmacology (Berl) 140:202-205
30. Tizabi Y, Russell LT, Johnson M, Darmani NA (2001) Nicotine attenuates DOI-induced head-twitch response in mice: Implications for Tourette syndrome. Prog Neuropsychopharmacol Biol Psychiatry 25:1445-1457
31. Tizabi Y, Al-Namaeh M, Manaye KF, Taylor RE (2003) Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells. Neurotox Res 5:315-322
32. Tizabi Y, Manaye KF, Smoot DT, Taylor RE (2004) Nicotine inhibits ethanol-induced toxicity in cultured cerebral cortical cells. Neurotox Res 6:311-316
33. Tizabi Y, Manaye KF, Taylor RE (2005) Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells. Neurotox Res 7:319-322
34. Toborek M, Son KW, Pudelko A, King-Pospisil K, Wylegala E, Malecki A (2007) ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. J Cell Biochem 100:279-292
35. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL (2005) Risk and protective factors for Parkinson's disease: A study in Swedish twins. Ann Neurol 57:27-33
36. Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M (2006) Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. J Neurochem 96:541-549